The estimated worldwide diabetes prevalence was 537 million adults between the ages of 20 and 79, with a prediction that by 2045, the number of adults with diabetes will have increased to 783 million.

This is a 26-week study.

To qualify for the study, you must be:

• Ages 19 and over
• Treated with multiple daily insulin injections for at least 6 months (with a daily basal insulin analogue and bolus insulin analogue regimen)
• HbA1c from 7.0–10.0% (53.0–85.8 mmol/mol), both inclusive, at screening confirmed by central laboratory analysis.
• no major cardio, renal, or other serious medical conditions.
• Other criteria may apply*

*There are multiple studies available to participate in and each may require different criteria to be approved as a participant.

To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our Contact page.